These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25655712)

  • 41. The universality of low-energy nano-emulsification.
    Anton N; Vandamme TF
    Int J Pharm; 2009 Jul; 377(1-2):142-7. PubMed ID: 19454306
    [TBL] [Abstract][Full Text] [Related]  

  • 42. From self-assembly fundamental knowledge to nanomedicine developments.
    Monduzzi M; Lampis S; Murgia S; Salis A
    Adv Colloid Interface Sci; 2014 Mar; 205():48-67. PubMed ID: 24182715
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles.
    Cohen-Sela E; Chorny M; Koroukhov N; Danenberg HD; Golomb G
    J Control Release; 2009 Jan; 133(2):90-5. PubMed ID: 18848962
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microemulsions as a surrogate carrier for dermal drug delivery.
    Azeem A; Khan ZI; Aqil M; Ahmad FJ; Khar RK; Talegaonkar S
    Drug Dev Ind Pharm; 2009 May; 35(5):525-47. PubMed ID: 19016057
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nano-emulsions and nanocapsules by the PIT method: an investigation on the role of the temperature cycling on the emulsion phase inversion.
    Anton N; Gayet P; Benoit JP; Saulnier P
    Int J Pharm; 2007 Nov; 344(1-2):44-52. PubMed ID: 17592746
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Self-microemulsifying drug delivery system improves curcumin dissolution and bioavailability.
    Wu X; Xu J; Huang X; Wen C
    Drug Dev Ind Pharm; 2011 Jan; 37(1):15-23. PubMed ID: 20738181
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A critical appraisal of microemulsions for drug delivery: part I.
    Sapra B; Thatai P; Bhandari S; Sood J; Jindal M; Tiwary A
    Ther Deliv; 2013 Dec; 4(12):1547-64. PubMed ID: 24304251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improved drug delivery using microemulsions: rationale, recent progress, and new horizons.
    Bagwe RP; Kanicky JR; Palla BJ; Patanjali PK; Shah DO
    Crit Rev Ther Drug Carrier Syst; 2001; 18(1):77-140. PubMed ID: 11326744
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Microemulsions as carriers for drugs and nutraceuticals.
    Spernath A; Aserin A
    Adv Colloid Interface Sci; 2006 Dec; 128-130():47-64. PubMed ID: 17229398
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Binary mixing of micelles using Pluronics for a nano-sized drug delivery system.
    Lee ES; Oh YT; Youn YS; Nam M; Park B; Yun J; Kim JH; Song HT; Oh KT
    Colloids Surf B Biointerfaces; 2011 Jan; 82(1):190-5. PubMed ID: 20850281
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Formation of ion pairing as an alternative to improve encapsulation and stability and to reduce skin irritation of retinoic acid loaded in solid lipid nanoparticles.
    Castro GA; Coelho AL; Oliveira CA; Mahecha GA; Oréfice RL; Ferreira LA
    Int J Pharm; 2009 Oct; 381(1):77-83. PubMed ID: 19647057
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: I. Formulation development.
    Rao SV; Shao J
    Int J Pharm; 2008 Oct; 362(1-2):2-9. PubMed ID: 18650038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bacterial biosurfactants, and their role in microbial enhanced oil recovery (MEOR).
    Khire JM
    Adv Exp Med Biol; 2010; 672():146-57. PubMed ID: 20545280
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
    Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM
    Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990
    [TBL] [Abstract][Full Text] [Related]  

  • 55. From conventional towards new - natural surfactants in drug delivery systems design: current status and perspectives.
    Savić S; Tamburić S; Savić MM
    Expert Opin Drug Deliv; 2010 Mar; 7(3):353-69. PubMed ID: 20201739
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preparation, characterization, sterility validation, and in vitro cell toxicity studies of microemulsions possessing potential parenteral applications.
    Nesamony J; Zachar CL; Jung R; Williams FE; Nauli S
    Drug Dev Ind Pharm; 2013 Feb; 39(2):240-51. PubMed ID: 22480266
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cationic Surfactants: Self-Assembly, Structure-Activity Correlation and Their Biological Applications.
    Zakharova LY; Pashirova TN; Doktorovova S; Fernandes AR; Sanchez-Lopez E; Silva AM; Souto SB; Souto EB
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31698783
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmaceutical prospects of biosurfactants produced from fungal species.
    Handa S; Aggarwal Y; Puri S; Chatterjee M
    J Basic Microbiol; 2022 Nov; 62(11):1307-1318. PubMed ID: 36257786
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microbe-Mediated Biosynthesis of Nanoparticles: Applications and Future Prospects.
    Koul B; Poonia AK; Yadav D; Jin JO
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34203733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of microemuslsions in advanced drug delivery.
    Sharma AK; Garg T; Goyal AK; Rath G
    Artif Cells Nanomed Biotechnol; 2016 Jun; 44(4):1177-85. PubMed ID: 25711493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.